Cerner Competitors

GoDaddy (NYSE:GDDY) and Cerner (NASDAQ:CERN) are both large-cap computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, institutional ownership, analyst recommendations, risk, valuation, dividends and profitability.

Analyst Ratings

This is a breakdown of recent ratings for GoDaddy and Cerner, as provided by MarketBeat.

GoDaddy presently has a consensus price target of $99.7143, suggesting a potential upside of 21.38%. Cerner has a consensus price target of $79.7778, suggesting a potential upside of 14.25%. Given GoDaddy's stronger consensus rating and higher possible upside, analysts clearly believe GoDaddy is more favorable than Cerner.

Earnings & Valuation

This table compares GoDaddy and Cerner's revenue, earnings per share (EPS) and valuation.

Cerner has higher revenue and earnings than GoDaddy. Cerner is trading at a lower price-to-earnings ratio than GoDaddy, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

97.2% of GoDaddy shares are owned by institutional investors. Comparatively, 83.0% of Cerner shares are owned by institutional investors. 0.5% of GoDaddy shares are owned by insiders. Comparatively, 0.3% of Cerner shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares GoDaddy and Cerner's net margins, return on equity and return on assets.

Volatility & Risk

GoDaddy has a beta of 0.96, suggesting that its share price is 4% less volatile than the S&P 500. Comparatively, Cerner has a beta of 0.76, suggesting that its share price is 24% less volatile than the S&P 500.

Summary

GoDaddy beats Cerner on 9 of the 15 factors compared between the two stocks.

Cerner (NASDAQ:CERN) and Leidos (NYSE:LDOS) are both large-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, risk, earnings, valuation and analyst recommendations.

Profitability

This table compares Cerner and Leidos' net margins, return on equity and return on assets.

Insider and Institutional Ownership

83.0% of Cerner shares are owned by institutional investors. Comparatively, 74.2% of Leidos shares are owned by institutional investors. 0.3% of Cerner shares are owned by insiders. Comparatively, 1.5% of Leidos shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Risk & Volatility

Cerner has a beta of 0.76, indicating that its stock price is 24% less volatile than the S&P 500. Comparatively, Leidos has a beta of 1.05, indicating that its stock price is 5% more volatile than the S&P 500.

Dividends

Cerner pays an annual dividend of $0.88 per share and has a dividend yield of 1.3%. Leidos pays an annual dividend of $1.36 per share and has a dividend yield of 1.5%. Cerner pays out 36.5% of its earnings in the form of a dividend. Leidos pays out 26.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cerner has increased its dividend for 1 consecutive years and Leidos has increased its dividend for 1 consecutive years. Leidos is clearly the better dividend stock, given its higher yield and lower payout ratio.

Earnings & Valuation

This table compares Cerner and Leidos' revenue, earnings per share (EPS) and valuation.

Leidos has higher revenue and earnings than Cerner. Leidos is trading at a lower price-to-earnings ratio than Cerner, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of recent recommendations for Cerner and Leidos, as provided by MarketBeat.

Cerner presently has a consensus price target of $79.7778, indicating a potential upside of 14.25%. Leidos has a consensus price target of $116.3636, indicating a potential upside of 27.77%. Given Leidos' stronger consensus rating and higher probable upside, analysts plainly believe Leidos is more favorable than Cerner.

Summary

Leidos beats Cerner on 11 of the 16 factors compared between the two stocks.

Cerner (NASDAQ:CERN) and Open Text (NASDAQ:OTEX) are both large-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, risk and institutional ownership.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Cerner and Open Text, as provided by MarketBeat.com.

Cerner presently has a consensus price target of $79.7778, indicating a potential upside of 14.25%. Open Text has a consensus price target of $55.50, indicating a potential upside of 20.55%. Given Open Text's stronger consensus rating and higher probable upside, analysts plainly believe Open Text is more favorable than Cerner.

Profitability

This table compares Cerner and Open Text's net margins, return on equity and return on assets.

Valuation & Earnings

This table compares Cerner and Open Text's revenue, earnings per share (EPS) and valuation.

Cerner has higher revenue and earnings than Open Text. Open Text is trading at a lower price-to-earnings ratio than Cerner, indicating that it is currently the more affordable of the two stocks.

Dividends

Cerner pays an annual dividend of $0.88 per share and has a dividend yield of 1.3%. Open Text pays an annual dividend of $0.80 per share and has a dividend yield of 1.7%. Cerner pays out 36.5% of its earnings in the form of a dividend. Open Text pays out 28.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cerner has increased its dividend for 1 consecutive years and Open Text has increased its dividend for 7 consecutive years. Open Text is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Risk and Volatility

Cerner has a beta of 0.76, indicating that its share price is 24% less volatile than the S&P 500. Comparatively, Open Text has a beta of 0.89, indicating that its share price is 11% less volatile than the S&P 500.

Institutional and Insider Ownership

83.0% of Cerner shares are held by institutional investors. Comparatively, 64.0% of Open Text shares are held by institutional investors. 0.3% of Cerner shares are held by company insiders. Comparatively, 10.6% of Open Text shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Open Text beats Cerner on 10 of the 17 factors compared between the two stocks.

Jack Henry & Associates (NASDAQ:JKHY) and Cerner (NASDAQ:CERN) are both large-cap computer and technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, institutional ownership, valuation, earnings and dividends.

Dividends

Jack Henry & Associates pays an annual dividend of $1.72 per share and has a dividend yield of 1.1%. Cerner pays an annual dividend of $0.88 per share and has a dividend yield of 1.3%. Jack Henry & Associates pays out 44.6% of its earnings in the form of a dividend. Cerner pays out 36.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Jack Henry & Associates has raised its dividend for 1 consecutive years and Cerner has raised its dividend for 1 consecutive years. Cerner is clearly the better dividend stock, given its higher yield and lower payout ratio.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for Jack Henry & Associates and Cerner, as provided by MarketBeat.com.

Jack Henry & Associates presently has a consensus target price of $176.8889, indicating a potential upside of 15.18%. Cerner has a consensus target price of $79.7778, indicating a potential upside of 14.25%. Given Jack Henry & Associates' higher possible upside, research analysts clearly believe Jack Henry & Associates is more favorable than Cerner.

Insider & Institutional Ownership

88.8% of Jack Henry & Associates shares are held by institutional investors. Comparatively, 83.0% of Cerner shares are held by institutional investors. 0.8% of Jack Henry & Associates shares are held by company insiders. Comparatively, 0.3% of Cerner shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Earnings and Valuation

This table compares Jack Henry & Associates and Cerner's gross revenue, earnings per share and valuation.

Cerner has higher revenue and earnings than Jack Henry & Associates. Cerner is trading at a lower price-to-earnings ratio than Jack Henry & Associates, indicating that it is currently the more affordable of the two stocks.

Volatility and Risk

Jack Henry & Associates has a beta of 0.52, suggesting that its stock price is 48% less volatile than the S&P 500. Comparatively, Cerner has a beta of 0.76, suggesting that its stock price is 24% less volatile than the S&P 500.

Profitability

This table compares Jack Henry & Associates and Cerner's net margins, return on equity and return on assets.

Summary

Jack Henry & Associates beats Cerner on 9 of the 16 factors compared between the two stocks.

CACI International (NYSE:CACI) and Cerner (NASDAQ:CERN) are both computer and technology companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, profitability, earnings, valuation, analyst recommendations, risk and institutional ownership.

Profitability

This table compares CACI International and Cerner's net margins, return on equity and return on assets.

Volatility & Risk

CACI International has a beta of 1.1, indicating that its stock price is 10% more volatile than the S&P 500. Comparatively, Cerner has a beta of 0.76, indicating that its stock price is 24% less volatile than the S&P 500.

Valuation and Earnings

This table compares CACI International and Cerner's top-line revenue, earnings per share and valuation.

Cerner has lower revenue, but higher earnings than CACI International. CACI International is trading at a lower price-to-earnings ratio than Cerner, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current recommendations and price targets for CACI International and Cerner, as reported by MarketBeat.

CACI International currently has a consensus target price of $286.6364, suggesting a potential upside of 30.13%. Cerner has a consensus target price of $79.7778, suggesting a potential upside of 14.25%. Given CACI International's stronger consensus rating and higher probable upside, research analysts clearly believe CACI International is more favorable than Cerner.

Insider and Institutional Ownership

84.8% of CACI International shares are owned by institutional investors. Comparatively, 83.0% of Cerner shares are owned by institutional investors. 1.6% of CACI International shares are owned by insiders. Comparatively, 0.3% of Cerner shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Science Applications International (NYSE:SAIC) and Cerner (NASDAQ:CERN) are both computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, dividends, earnings, valuation and risk.

Valuation and Earnings

This table compares Science Applications International and Cerner's top-line revenue, earnings per share (EPS) and valuation.

Cerner has lower revenue, but higher earnings than Science Applications International. Science Applications International is trading at a lower price-to-earnings ratio than Cerner, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

Science Applications International has a beta of 1.01, indicating that its share price is 1% more volatile than the S&P 500. Comparatively, Cerner has a beta of 0.76, indicating that its share price is 24% less volatile than the S&P 500.

Dividends

Science Applications International pays an annual dividend of $1.48 per share and has a dividend yield of 1.7%. Cerner pays an annual dividend of $0.88 per share and has a dividend yield of 1.3%. Science Applications International pays out 26.1% of its earnings in the form of a dividend. Cerner pays out 36.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Science Applications International has increased its dividend for 1 consecutive years and Cerner has increased its dividend for 1 consecutive years. Science Applications International is clearly the better dividend stock, given its higher yield and lower payout ratio.

Insider and Institutional Ownership

77.0% of Science Applications International shares are held by institutional investors. Comparatively, 83.0% of Cerner shares are held by institutional investors. 0.9% of Science Applications International shares are held by insiders. Comparatively, 0.3% of Cerner shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares Science Applications International and Cerner's net margins, return on equity and return on assets.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Science Applications International and Cerner, as reported by MarketBeat.

Science Applications International currently has a consensus price target of $99.8750, indicating a potential upside of 14.92%. Cerner has a consensus price target of $79.7778, indicating a potential upside of 14.25%. Given Science Applications International's stronger consensus rating and higher possible upside, equities analysts plainly believe Science Applications International is more favorable than Cerner.

Summary

Science Applications International beats Cerner on 9 of the 16 factors compared between the two stocks.